- Thanks Walter, and I think that's one of the articles I read before... Archived Message
Posted by David Macilwain
on May 4, 2020, 1:00 pm, in reply to "You might be interested in this David"
| which helped to give me some background and feeling about efficacy. That is needed to cope with all the contrary stuff from trials that allegedly show no effect or bad effects. Also most notable is that Remdesevir now gets approval to make billions for GILEAD, while HCQ is too cheap for anyone to make money from, and so they try to ignore it. I still think it has the greatest promise, and so do a number of high profile backers, including Sanofi. |